In the Voelcker lab, we aim to gain a deeper understanding of the interactions between nanostructured materials and human cells and tissues, and their biomolecular products. To that effect, we are developing nanostructured materials and surface chemistries, with a focus on electrochemically etched meso- and macroporous materials. These systems are then optimised for applications in biosensing, drug delivery, regenerative medicine, microfluidics, and others.
Feel free to contact us regarding open positions, collaboration, and beyond.
Latest Papers
- Sensing the future of cell therapy manufacturing
by Masoud Khazaei on September 3, 2026 at 10:00 amCell therapies are increasingly manufactured in closed, automated culture systems, yet decisions about cell quality, safety, and release still rely largely on sparsely executed, destructive, and […]
- Dual-targeting poly(2-oxazoline)-coated porous silicon nanoparticles for improving osteosarcoma therapyby Mona A Abdelmoneem on September 1, 2026 at 10:00 am
Osteosarcoma is the most prevalent malignant bone tumor in children and adolescents. Current treatment of this aggressive tumor with surgery and chemotherapy is hindered by the non-selectivity of […]
- Programmable Antimicrobial Nanostructured Surfaces: Opportunities and Hurdles for Clinical Translationby Thuy P T Nguyen on August 30, 2026 at 10:00 am
Surfaces with programmable nanostructures represent a promising antimicrobial strategy that eradicates bacterial pathogens through physical membrane disruption and/or mechanically induced oxidative […]
- A Single-Enzyme Electrochemical Biosensor for Lactose Detection in Human Breastmilk and Dairy Productsby Raquel Sánchez-Salcedo on August 22, 2026 at 10:00 am
Lactose, a disaccharide found predominantly in human breast milk and dairy products, plays a vital role in human health and nutrition. While lactose is an essential energy source particularly for […]
- Transferrin-Conjugated Polymeric Nanoparticles via Polymerization-Induced Self-Assembly for Enhanced BBB Transport and Glioblastoma Therapyby Weisen Zhang on August 17, 2026 at 10:00 am
Transferrin-coated nanoparticles show promise in delivering chemotherapeutic drugs across biological barriers for treating glioblastoma multiforme (GBM). Employing a synthetic approach integrating […]
